Sedation with remimazolam versus propofol for colon polyp removal
Official title: A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy
Run by Clinical Hospital Centre Zagreb · NCT07456111 · Data updated 2026-11-12
This test checks whether remimazolam besylate plus sufentanyl gives more stable blood pressure and breathing than propofol plus sufentanyl for adults 18–60 having colonoscopic polypectomy.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Clinical Hospital Centre Zagreb Academic / other |
| Locations | 1 site (Zagreb) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | November 30, 2027 |
| Study ends | December 30, 2028 |
| Registry record updated | March 6, 2026 |
| Trial ID | NCT07456111 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–60 with one or more colonic polyps scheduled for colonoscopic polypectomy, ASA I–III, BMI 18.5–29.9 kg/m2, who provide informed consent are the intended participants.
✕Probably not a fit
Patients over 60, with BMI >29.9, ASA IV–V, significant cardiac, pulmonary, or renal disease, high aspiration risk, or other exclusion criteria are unlikely to receive benefit from these results.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, controlled comparison enrolling 90 adults undergoing colonoscopic polypectomy, with 45 patients assigned to remimazolam besylate plus sufentanyl and 45 to propofol plus sufentanyl. The primary focus is on circulatory and respiratory stability during procedural sedation, specifically the incidence of hypotension and respiratory depression. Secondary measures include sedation success and timing outcomes such as time to adequate sedation, time to full consciousness, and time to complete recovery. All procedures are performed at the Clinical Hospital Centre Zagreb with standard IV access and monitoring.
Why it matters
Potential benefit: If successful, this approach could reduce episodes of low blood pressure and breathing problems during polypectomy and speed safer recovery.
How similar studies have gone: Prior procedural sedation studies suggest remimazolam often causes less hemodynamic and respiratory depression than propofol, but direct head-to-head data specifically for polypectomy are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients both male and female * ages 18 to 60 years, * with one or more colonic polyps confirmed by colonoscopy and scheduled for a colonoscopy and polypectomy * The duration of the colonoscopy ranges from 30 to 50 minutes. * ASA status (American Society of Anaesthesiologists physical status) I-III. * BMI (Body mass index) 18.5-29.9 kg/m2. * Only patients who signed an informed consent waiver and consented to participate in the research study. Exclusion Criteria: * Patients aged \>60 years * ASA status IV-V, * BMI \>29.9 kg/m2, * a high risk of vomiting, regurgitation and/or aspiration of gastric contents. * Patients with: * uncontrolled hypertension (systolic pressure \>160 mmHg), * heart disease (cardiomyopathy, cardiac-rhythm disorder, left ventricular ejection fraction \<45%, stenosis or heart valve insufficiency and coronary heart disease) * lung disease (pneumonia, chronic obstructive pulmonary disease, asthma and pulmonary tumors), * kidney diseases (kidney failure, GF 30/59 ml/min/1.73m2), * liver diseases, * coagulation disorders * lymphatic tissue diseases * extended malignant disease. * History of allergy on nutritional allergens including soy bean, benzodiazepines, propofol or opioids. * Patients who currently use analgesic medications or other psycho-pharmaceuticals. * History of illicit drug use. * Children, pregnant and nursing women. * Alcohol dependency. * Patients involved in other clinical research studies, * patients who refused to take part in the research or have not signed the written informed consent form.
Where it's running
-
UHC Zagreb
Zagreb, Croatia Recruiting
Study contacts
- Study coordinator: Željko Drvar, MD, PhD
- Email: zeljko.drvar@kbc-zagreb.hr
- Phone: 003851 2388 888
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Safety of sedation with non-anesthesiologist-administered propofol during interventional endoscopy
This study tests how safe and effective the use of propofol given by non-anesthesiologists is during interventional gastrointestinal endoscopy for adults.
-
Using EEG to guide sedation and pain relief in ICU patients
This study tests if using a special device to monitor brain activity can help doctors give the right amount of sedation and pain relief to ICU patients on ventilators, aiming to improve their recovery.
-
Advanced monitoring system for sedation in ICU patients
This study is testing a new monitoring system that uses machine learning to see if it can better track sedation levels in critically ill patients in the ICU compared to standard methods.
-
Teaching doctors to tell Paris-class polyps apart using real and AI-generated colon images
This trial tests if training doctors with AI-generated colon polyp images helps them learn to classify polyps by the Paris system better than training with real images.
-
Autonomous AI vs AI-assisted human optical diagnosis for colorectal polyps
A computer-aided AI system is tested to predict the nature of colorectal polyps during colonoscopy and compare its autonomous predictions with those of human doctors using AI assistance.
-
Using AI to improve polyp detection during colonoscopy
This study is testing if using artificial intelligence during colonoscopy can help doctors find more polyps in people over 50 and tell which ones are harmless or harmful.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.